James Hardiman's guest appearances

James Hardiman

The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified

Village Global's Venture Stories

The Art Of Listening To Your Body

I Went Down To The River

Aydin Senkut

Ash Fontana

Leo Polovets

Samir Kaji

Chris Douvos

Rebecca Kaden

Cyan Banister

Erik Torenberg

Jenny Rooke

Reid Hoffman

Beezer Clarkson

Charles Hudson

Nikhil Basu Trivedi

Sarah Tavel

Semil Shah

OwlTail

James Hardiman '93 and I chat about memories watched as a young fan and memories lived as a player and the lasting impressions they've had. James even shares his first Tang with us. In the Ask Coach segment, my Dad answers what "the challenges of being a first time Head Coach" were.

James Hardiman '93 and I chat about memories watched as a young fan and memories lived as a player and the lasting impressions they've had. James even shares his first Tang with us. In the Ask Coach segment, my Dad answers what "the challenges of being a first time Head Coach" were.

Episode 02- James Hardiman ‘93

Scott Barclay

On this episode of Health Stories, Erik is joined by James Hardiman (@hardimanjames) and Scott Barclay (@SABarclay) of Data Collective, a deep tech and AI venture fund.Scott and James are live in-studio with Erik to discuss a number of interesting topics around the health space. Scott and James explain what they mean when they say innovation in the last 50 years was driven by the semiconductor but the next 50 years will be driven by biotechnology. The three of them discuss the state of the healthcare in the US and how entrepreneurs and investors can “take a crowbar to the health system.” They discuss the misaligned incentives in the US healthcare system and how payers might be incentivized to pay for preventative care. They mention that the US pays about 18% of GDP for healthcare while still having poorer health outcomes than countries in Northern Europe that pay about 9% of GDP. They explain why they are predicting a contraction in the number of hospitals in the US and why there are double to triple the number of hospitals per capita in the US than there are in a country like Denmark. They also talk about a number of interesting developments in health tech these days, including a company that can verify the integrity of a supply chain by analyzing the microbiome of the resultant products and a company that is using computer vision to detect falls.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Colin Campbell is our audio engineer and the show is produced by Brett Bolkowy.

On this episode of Health Stories, Erik is joined by James Hardiman (@hardimanjames) and Scott Barclay (@SABarclay) of Data Collective, a deep tech and AI venture fund. Scott and James are live in-studio with Erik to discuss a number of interesting topics around the health space. Scott and James explain what they mean when they say innovation in the last 50 years was driven by the semiconductor but the next 50 years will be driven by biotechnology. The three of them discuss the state of the healthcare in the US and how entrepreneurs and investors can “take a crowbar to the health system.” They discuss the misaligned incentives in the US healthcare system and how payers might be incentivized to pay for preventative care. They mention that the US pays about 18% of GDP for healthcare while still having poorer health outcomes than countries in Northern Europe that pay about 9% of GDP. They explain why they are predicting a contraction in the number of hospitals in the US and why there are double to triple the number of hospitals per capita in the US than there are in a country like Denmark. They also talk about a number of interesting developments in health tech these days, including a company that can verify the integrity of a supply chain by analyzing the microbiome of the resultant products and a company that is using computer vision to detect falls. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at <a href="http://villageglobal.vc" rel="nofollow" target="_blank">villageglobal.vc</a> or get in touch with us on Twitter @villageglobal. Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Colin Campbell is our audio engineer and the show is produced by Brett Bolkowy.

Health Stories: Computational Care, Computational Biology, and "Taking a Crowbar to the Health System" with Scott Barclay and James Hardiman

James Hardiman of Data Collective joins Nick to discuss The Deep Tech Debate: Why Invest in a Capital Intensive, Long Time-to-Exit Category?. In this episode, we cover:  James' definition of deep tech The segments within the category How this area differs from others Types of founders and founder profiles that he looks for Why he's willing to invest in a capital intensive, long-time horizon category Why deep tech will drive the biggest outcomes How founders are able to de-risk deep tech opportunities where many others don't The waves that are coming in deep tech and finally how some consumer, social companies became deep tech companies by accident.    To listen more, please visit http://fullratchet.net/podcast-episodes/  for all of our other episodes. Also, follow us on twitter @TheFullRatchet for updates and more information.

James Hardiman of Data Collective joins Nick to discuss The Deep Tech Debate: Why Invest in a Capital Intensive, Long Time-to-Exit Category?. In this episode, we cover: <ul> <li>James' definition of deep tech</li> <li>The segments within the category</li> <li>How this area differs from others</li> <li>Types of founders and founder profiles that he looks for</li> <li>Why he's willing to invest in a capital intensive, long-time horizon category</li> <li>Why deep tech will drive the biggest outcomes</li> <li>How founders are able to de-risk deep tech opportunities where many others don't</li> <li>The waves that are coming in deep tech</li> <li>and finally how some consumer, social companies became deep tech companies by accident.</li> </ul> To listen more, please visit <a href="http://fullratchet.net/podcast-episodes/" rel="nofollow" target="_blank">http://fullratchet.net/podcast-episodes/ </a> for all of our other episodes. Also, follow us on twitter <a href="https://twitter.com/TheFullRatchet" rel="nofollow" target="_blank">@TheFullRatchet</a> for updates and more information.

158. The Deep Tech Debate: Why Invest in a Capital Intensive, Long Time-to-Exit Category? (James Hardiman)